Mannitol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00742 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | acute pulmonary heart disease | KG + DL |
| 3 | exercise-induced malignant hyperthermia | KG + DL |
| 4 | malignant hyperthermia, susceptibility to | KG + DL |
| 5 | familial periodic paralysis | KG + DL |
| 6 | hypokalemic periodic paralysis | KG + DL |
| 7 | congenital multicore myopathy with external ophthalmoplegia | KG + DL |
| 8 | moderate multiminicore disease with hand involvement | KG + DL |
| 9 | nephrogenic diabetes insipidus | KG + DL |
| 10 | central core myopathy | KG + DL |
| 11 | King-Denborough syndrome | KG + DL |
| 12 | renal tubule disease | KG + DL |
| 13 | Senior-Boichis syndrome | KG + DL |
| 14 | psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome | KG + DL |
| 15 | malignant hyperthermia of anesthesia | KG + DL |
| 16 | RHYNS syndrome | KG + DL |
| 17 | cranioectodermal dysplasia | KG + DL |
| 18 | familial hyperlipidemia | KG + DL |
| 19 | thyrotoxic periodic paralysis, susceptibility to | KG + DL |
| 20 | periodic paralysis (disease) | KG + DL |
| 21 | thyrotoxic periodic paralysis | KG + DL |
| 22 | potassium deficiency disease | KG + DL |
| 23 | Prinzmetal angina | KG + DL |
| 24 | mitochondrial DNA depletion syndrome, hepatocerebrorenal form | KG + DL |
| 25 | HELIX syndrome | KG + DL |
| 26 | hereditary renal hypouricemia | KG + DL |
| 27 | myopathy, centronuclear | KG + DL |
| 28 | Jeune syndrome | KG + DL |
| 29 | X-linked centronuclear myopathy | KG + DL |
| 30 | Dent disease | KG + DL |
| 31 | chronic pulmonary heart disease | KG + DL |
| 32 | frontal lobe epilepsy | KG + DL |
| 33 | Senior-Loken syndrome | KG + DL |
| 34 | Alstrom syndrome | KG + DL |
| 35 | hypotonia-cystinuria syndrome type 1 | KG + DL |
| 36 | homozygous familial hypercholesterolemia | KG + DL |
| 37 | hypoalphalipoproteinemia | KG + DL |
| 38 | progressive encephalopathy with leukodystrophy due to DECR deficiency | KG + DL |
| 39 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 40 | primitive portal vein thrombosis | KG + DL |
| 41 | idiopathic copper-associated cirrhosis | KG + DL |
| 42 | hepatoportal sclerosis | KG + DL |
| 43 | hepatopulmonary syndrome | KG + DL |
| 44 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 45 | chronic renal failure syndrome | KG + DL |
| 46 | familial visceral myopathy | KG + DL |
| 47 | familial hypercholesterolemia | KG + DL |
| 48 | gastroduodenitis | KG + DL |
| 49 | subarachnoid hemorrhage (disease) | KG + DL |
| 50 | trichotillomania | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.